BlinkLab is an ASX listed digital healthcare company founded by neuroscientists at Princeton University that has over the past several years developed a smartphone based diagnostic platform for autism, ADHD, and other neuropsychiatric conditions.
BlinkLab’s most advanced product is an autism diagnostic test that leverages the power of smartphones, neuroscience and AI to deliver screening tests specifically designed for young children. This marks a significant advancement, considering traditional diagnoses typically occur around five years of age, often missing the crucial early window for effective intervention.
BlinkLab is led by an experienced management team and directors with a proven track record in building companies and vast knowledge in neuroscience, digital healthcare, computer vision, AI and machine learning. Our Scientific Advisory Board consists of leading experts in the field of autism and brain development allowing us to bridge the most advanced technological innovations with groundbreaking scientific research.
Learn more on the BlinkLab website.
